Both anti-VEGF and surgical treatments improve VA in AMD-related submacular hemorrhage, with no statistically significant difference between the two treatments. Anti-VEGF injections may be associated ...
Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher ...
Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...
An estimated 10 million Americans show evidence of Age-Related Macular Degeneration (AMD), a progressive eye condition that can destroy “straight-ahead” vision, according to Dr. Brad Bodkin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results